Foghorn Therapeutics Inc. (FHTX) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of$0.55. This compares to loss of $0.73 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -7.27$0.79 per share when it actually produced a loss of $0.57, delivering a surprise of 27.85%. Over the last four quarters, the company ...